12:00 AM
 | 
Aug 10, 2009
 |  BioCentury  |  Emerging Company Profile

Going long in RNAi: Sidebar: Corporate Profile

Dicerna Pharmaceuticals Inc.

Watertown, Mass.

Technology: Dicer substrate double-stranded RNA

Disease focus: Cancer, metabolic

Clinical status:...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >